CCC

Dreka Gates, previously known for managing her husband Kevin Gates‘s music career and upcoming speaker at the Benzinga Cannabis Capital Conference, has carved a new path in the cannabis industry with her venture, Love’s Harvest. Gates utilized the unexpected break from music tours...

CCELL, a renowned name in vaporizer technology, appointed Angela Pih as chief marketing officer. Pih, with a distinguished history of brand development across fashion, beauty, and, notably, cannabis, is set to infuse her depth of experience into enhancing CCELL’s consumer engagement and...

Research published in the Journal of Dental Research has shown CBD’s potential as a safe and effective alternative to opioids for acute dental pain, marking a significant advancement in pain management and opioid alternative research. The study, conducted by scientists from...

In a recent discussion on Benzinga’s Cannabis Insider, Michael Wang, the co-CEO of Ispire Technology, shared insights into the company’s recent achievements and future directions in the cannabis vaping industry. The conversation highlighted Ispire’s second-quarter earnings,...

Recent advancements within the field of mental health with the use of psilocybin-assisted therapy, as well as Colorado’s forward-thinking legislation about this therapy, have proven exciting. Psilocybin-assisted therapy showcased promising results in treating Generalized Anxiety Disorder (GAD...

Circle March 20 on your calendars! Starting at 10:25 a.m. EST Wednesday, the Benzinga Virtual Healthcare Summit 2024 is the place to be. Imagine a digital room buzzing with the likes of Beachbody’s Mark Goldston, Autonomix Medical’s Lori Bisson, and IGC Pharma’s Ram Mukunda (NYSE:...

Prime Harvest, a name well-known in the Southern California medical cannabis market, has grown exponentially since its inception in 2017. Originating as a cannabis producer in San Diego, the company launched itself into the industry as a leader, driven by a philosophy of trailblazing rather than...

How can cannabis brands expand to multiple states while maintaining consistent quality and authenticity? Industry experts, including Crystal Millican, SVP of Marketing & Retail at Cookies; Christine Smith, founder and CEO of Grön; Josh Hirschey, president of Timeless Refinery and Kit...

At the recent Benzinga Cannabis Capital Conference in Chicago, industry experts gathered to explore the cannabis pre-roll market, provide vital advice for brands, and assist investors in evaluating their performance and strategies. Panelists, including Brett Novey, CEO of PharmaCann Inc., Harrison...

How can the cannabis industry promote waste management and a circular economy while meeting demand? At the Benzinga Cannabis Capital Conference, CEOs Will Bowden of Grasshopper Farms and Barbara Fox of Cannabiz Supply shared their insights. Sustainable Solutions and Environmental Stewardship in...

At the recent Benzinga Cannabis Capital Conference in Chicago, a panel of industry experts took the stage to explore the potential of local cannabis brands. They delved into key themes such as community engagement, the challenge of scaling while preserving authenticity and the need for...

At the recent Benzinga Cannabis Capital Conference in Chicago, experts explored the role of small banks and credit unions in the cannabis industry. With regulatory challenges and evolving services, these institutions are vital for the sector's growth. What drives these smaller players into...

At the last Benzinga Cannabis Capital Conference, industry experts discussed the rising demand for rare cannabinoids, which are lesser-known compounds found in the cannabis plant known for their unique therapeutic properties. Panelists Jerry Griffin VP of Sales & Marketing from BayMedica...

In a time when product innovation in the cannabis industry is at an ebb, Morgan Paxhia, managing partner at Poseidon Investment Management, sees potential for a resurgence. What Happened: Speaking exclusively to Benzinga at its Cannabis Capital Conference in late September, Paxhia noted that while...

Rescheduling cannabis from a schedule one drug to a schedule three drug was top of mind for former U.S. Rep. Ed Perlmutter, who spoke exclusively to Benzinga at its Cannabis Capital Conference in late September. The former U.S. representative, who has been an influential figure in the cannabis...